Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
Abstract Understanding the molecular basis of fibrosis, the lethal complication of COVID-19, is urgent. By the analysis of RNA-sequencing data of SARS-CoV-2-infected cells combined with data mining we identified genes involved in COVID-19 progression. To characterize their implication in the fibrosi...
Saved in:
Main Authors: | Elmira R. Vagapova, Timofey D. Lebedev, Vladimir S. Prassolov |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/af657faedb774b16b9c79f1776b9032d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
by: Elmira R. Vagapova, et al.
Published: (2021) -
Fibrotic microtissue array to predict anti-fibrosis drug efficacy
by: Mohammadnabi Asmani, et al.
Published: (2018) -
Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations
by: Yang W, et al.
Published: (2020) -
A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes
by: Alexander Burov, et al.
Published: (2021) -
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
by: Katy M. Roach, et al.
Published: (2018)